Regulation of Muscle Mass by Follistatin and Activins
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Myostatin is a TGF-β family member that normally acts to limit skeletal muscle mass. Follistatin is a myostatin-binding protein that can inhibit myostatin activity in vitro and promote muscle growth in vivo. Mice homozygous for a mutation in the Fst gene have been shown to die immediately after birth but have a reduced amount of muscle tissue, consistent with a role for follistatin in regulating myogenesis. Here, we show that Fst mutant mice exhibit haploinsufficiency, with muscles of Fst heterozygotes having significantly reduced size, a shift toward more oxidative fiber types, an impairment of muscle remodeling in response to cardiotoxin-induced injury, and a reduction in tetanic force production yet a maintenance of specific force. We show that the effect of heterozygous loss of Fst is at least partially retained in a Mstn-null background, implying that follistatin normally acts to inhibit other TGF-β family members in addition to myostatin to regulate muscle size. Finally, we present genetic evidence suggesting that activin A may be one of the ligands that is regulated by follistatin and that functions with myostatin to limit muscle mass. These findings potentially have important implications with respect to the development of therapeutics targeting this signaling pathway to preserve muscle mass and prevent muscle atrophy in a variety of inherited and acquired forms of muscle degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We and others have previously demonstrated that growth differentiation factor-8 (GDF8; also known as myostatin) and activin A (ActA) are the two major ligands mediating the muscle-minimization actions of ActRIIA/B receptors22,26–30.”
From GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates (2025) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The function of MSTN in muscle is at least partially redundant with that of another TGF-β family member, activin A (13–16).”
From Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight (2020) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FST acts as an inhibitor of members of the TGF-β superfamily, including myostatin and activins [185,186], and can function as a promoter of skeletal muscle growth [187].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [187]
In the citing paper
“Both follistatin and GASPs inhibit the activities of GDF11 and myostatin; accordingly, follistatin (Fst)-heterozygous47 and Gasp1-null or Gasp2-null48 mice have smaller muscles and increased GDF11 and myostatin bioactivity.”
From The central role of muscle stem cells in regenerative failure with aging (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Self-citationRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 3×
“Follistatin is a potent myostatin inhibitor that can cause dramatic increases in muscle mass when overexpressed as a transgene in mice (18, 21, 22).”
BackgroundSelf-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Self-citationClop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice carrying the targeted allele were crossed to EIIa-cre transgenic mice (33) to generate mice in which recombination had occurred between the outside LoxP sites (denoted by triangles), thereby resulting in a mutant allele in which exons 3–5 were completely deleted in the germline.”
MethodInduction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Self-citationThe regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Cited by
Items 201–277 of 277
Functional replacement of myostatin with GDF-11 in the germline of mice
Lee, S., Lehar, A., Rydzik, R., Youngstrom, D. W., Bhasin, S., Liu, Y., & Germain‐Lee, E. L. (2022) · Skeletal Muscle · doi:10.1186/s13395-022-00290-z · Cited by 8
Self-citationCawthon, P. M., Patel, S., Newman, A. B., Bhasin, S., Peng, L., Tracy, R. P., Kizer, J. R., Lee, S., Ferrucci, L., Ganz, P., et al. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad045 · Cited by 11
Self-citationDeficiency of GDF-11 Accelerates TAC-Induced Heart Failure by Impairing Cardiac Angiogenesis
Zhu, J., Zhang, N., Zhao, Y. F., Liu, Q., Wang, Y., Chen, M., Ma, Q., Dong, A., Wang, Y., & Yu, H. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.11.004 · Cited by 10
“Heart-derived activin A also influences the cardiac cachexic states by acting on skeletal muscle in an endocrine manner.(45) These factors appear to function as endocrine hormones.”
BackgroundRashidlamir, A., Hosseini, S. R. A., Hejazi, K., & Motevalli, M. S. (2016) · Journal of Cardiovascular and Thoracic Research · doi:10.15171/jcvtr.2016.33 · Cited by 10
Nguyen, H. Q., Iskenderian, A., Ehmann, D. E., Jasper, P., Zhang, Z., Rong, H., Welty, D. F., & Narayanan, R. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12518 · Cited by 9
The quasi-parallel lives of satellite cells and atrophying muscle
Biressi, S., & Gopinath, S. D. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00140 · Cited by 11
“Follistatin is a powerful regulator of muscle mass, which exerts its function mainly by inhibiting the action of Myostatin and Activins, both of which are implicated as negative regulators of muscle growth (Link and Nishi, 1997; Souza et al., 2008; Gilson et al., 2009; Lee et al., 2010).”
BackgroundExpression Profiling of Activin type IIB Receptor During Ontogeny in Broiler and Indigenous Chicken
Vishnu, P. G., Bhattacharya, T. K., Kumar, T. V., CHATTERJEE, R. N., Kumar, G. V. P. P. S. R., Paswan, C., Reddy, D. K., & Prasad, A. R. (2016) · Animal Biotechnology · doi:10.1080/10495398.2016.1194287 · Cited by 11
“AB) have been shown to inhibit the growth of skeletal muscle during chick development, by inhibiting the proliferation and differentiation of myoblasts (10, 20, 21).”
BackgroundProduction of bioactive chicken (Gallus gallus) follistatin-type proteins in E. coli
Lee, S. B., Park, S., & Kim, Y. (2015) · AMB Express · doi:10.1186/s13568-015-0142-3 · Cited by 9
Self-citationCombined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth
Männistö, A., Tonttila, K., Ortega‐Alonso, A., Nurmi, H. J., Uusitalo‐Kylmälä, L., Hemanthakumar, K. A., Saikkala, E., Myllykangas, S., Vertainen, S., Nissinen, T. A., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00966.2024 · Cited by 8
Karimifard, M., Arazi, H., & Mehrabani, J. (2023) · Stresses · doi:10.3390/stresses3010022 · Cited by 8
“MSTN is expressed and secreted in muscle cells, which is less expressed and secreted in various tissues such as the brain and adipose tissue, and has functions such as inhibiting the hypertrophic growth of muscle cells and the prevention of proliferation of these cells (inhibition of hyperplastic growth) [12].”
BackgroundVitamin D and Physical Activity
Koundourakis, N. E., & Margioris, A. N. (2017) · InTech eBooks · doi:10.5772/65103 · Cited by 6
“Indeed, vitamin D increases the size of MHC type II‐positive myotubes [61, 64] and the cross‐ sectional area (CSA) of skeletal muscle fibers [65].”
BackgroundTranscriptomic profile of semitendinosus muscle of bulls of different breed and performance
Ciecierska, A., Motyl, T., & Sadkowski, T. (2020) · Journal of Applied Genetics · doi:10.1007/s13353-020-00577-1 · Cited by 7
Korzonek-Szlacheta, I., Hudzik, B., Zubelewicz‐Szkodzińska, B., Czuba, Z. P., Szlacheta, P., & Tomasik, A. R. (2024) · Nutrients · doi:10.3390/nu16081227 · Cited by 8
Paltsyn, A. A. (2020) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2020.01.135-141 · Cited by 7
Regulation of Hepatic Follistatin Expression at Rest and during Exercise in Mice
Peppler, W. T., Castellani, L. N., Root-McCaig, J., Townsend, L. K., SUTTON, C. D., Frendo‐Cumbo, S., Medak, K. D., MacPherson, R. E. K., Charron, M. J., & Wright, D. C. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001893 · Cited by 7
The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
Kukes, V. G., Olefir, Y. V., Романов, Б. К., Prokofiev, A. B., Parfenova, E. V., Boldyreva, M. A., Goroshko, O. A., Parfenova, O. K., Газданова, А. А., & Demchenkova, E. Y. (2019) · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · doi:10.30895/1991-2919-2019-9-4-256-260 · Cited by 6
“Фоллистатин синтезируется в разных органах и тканях: в мышцах, гипофизе, половой системе, сердце, фибробластах, дендритных и тучных клетках, макрофагах, эпителии дыхательных путей и Т-клетках, но основным источником циркулирующего фоллистатина является печень [1].”
Jiang, X., Huang, C.-X., Zhong, S.-S., Sun, C., & Zou, S. (2016) · Aquaculture · doi:10.1016/j.aquaculture.2016.11.014 · Cited by 6
Wang, K., Wang, S., Ji, X., Chen, D., Shen, Q., Yu, Y., Xiao, W., Wu, P., Yuan, J., Gu, Y., et al. (2022) · Genome · doi:10.1139/gen-2021-0105 · Cited by 5
Identification of the crucial molecular events during the large-scale myoblast fusion in sheep
Wei, C., Li, L., Su, H.-W., Xu, L., Lü, J., Zhang, L., Liu, W., Ren, H., & Du, L. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00184.2013 · Cited by 6
Skeletal Muscle in Spinal Muscular Atrophy As an Opportunity for Therapeutic Intervention
Verche, V. L., Sunshine, S., Hammers, D. W., Sweeney, H. L., & Paushkin, S. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00021-5 · Cited by 7
Liu, X., Zhang, H., Xue, Q., Pan, W., & Zhang, A. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143082 · Cited by 5
Anuja, A. K., Bhadu, D., Naveen, R., Singh, M. K., Rai, M. K., Agarwal, V., & Gupta, L. (2021) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_309_20 · Cited by 5
Tgf-β Signaling In Duchenne Muscular Dystrophy
Kemaladewi, D. U., Hoen, P. A. C. ’., ten Dijke, P., van Ommen, G. J., & Hoogaars, W. M. H. (2012) · Future Neurology · doi:10.2217/fnl.12.3 · Cited by 6
Getting the Skinny on Follistatin and Fat
Li, J.-X., & Cummins, C. L. (2017) · Endocrinology · doi:10.1210/en.2017-00223 · Cited by 6
“Follistatin (Fst) is a secreted glycoprotein that functions to bind and inhibit the activity of members of the TGF-b superfamily and is a well-known promoter of skeletal muscle growth (13, 17, 18).”
BackgroundExercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential
Aslam, M. A., Lee, J., Bowen, T. S., & Huh, J. Y. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01624-x · Cited by 10
“In preclinical studies, follistatin promotes muscle anabolism and improves insulin action through AKT, p70S6K, TBC1D1/4, and PAK1 signaling (Lee et al. 2010; Han et al. 2019).”
Kurose, S., Onishi, K., Miyauchi, T., Takahashi, K., & Kimura, Y. (2023) · Endocrine Research · doi:10.1080/07435800.2023.2253452 · Cited by 4
“FST and MST have opposite functions: MST promotes protein degradation and inhibits protein synthesis in skeletal muscles, whereas FST inhibits MST and promotes skeletal muscle growth.(29,30) High serum FST levels were found to be associated with the risk of type 2 diabetes mellitus,(31) sarcopenia,(32) decreased walki…”
BackgroundPhysical Activity, Body Composition, Serum Myokines and the Risk of Death in Hemodialysis Patients
Koźma-Śmiechowicz, M. A., Gajewski, B., Fortak, P., Gajewska, K., & Nowicki, M. P. (2023) · Medicina · doi:10.3390/medicina59112020 · Cited by 4
“Follistatin, which belongs to the same TGF-β family, is an inhibitor of myostatin that promotes muscle proliferation and growth [15].”
BackgroundFodor, J., Gomba-Tóth, A., Oláh, T., Almássy, J., Zádor, E., & Csernoch, L. J. (2017) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-017-9474-8 · Cited by 4
“Our results are consistent with a range of previous observations on FS counteracting the activin signaling pathway (Lee et al. 2010) which is known to influence both muscle hyperplasia and hypertrophy (Lee and McPherron 2001).”
BackgroundResultBoido, M., Butenko, O., Filippo, C., Schellino, R., Vrijbloed, J. W., Fariello, R. G., & Vercelli, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228653 · Cited by 4
Liu, H., Li, X., Sun, L., Wang, H., Zhang, R., Yang, C., Li, L., Wang, J., He, H., & Krumm, C. S. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.12.003 · Cited by 4
“Follistatin is another important gene that is an upstream regulator of myostatin in the TGF-β pathway and can efficiently suppress its activities [27].”
BackgroundInfluentialHibernation as a model for skeletal muscle preservation
Porczak, A. E., & Feng, N. Y. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15389 · Cited by 3
“14 Therefore, different species and muscle types may utilize differential regulation of FOXO proteins for muscle maintenance during hibernation.”
Alonso-Puyo, J., Izagirre-Fernandez, O., Crende, O., Seco‐Calvo, J., Fernández‐Atutxa, A., Fernández‐Lázaro, D., García-Gallastegui, P., & Sanz, B. (2024) · Proteomes · doi:10.3390/proteomes12040034 · Cited by 3
“This protein is a myostatin-binding protein that can inhibit myostatin activity in vitro and promotes muscle growth in vivo [9,12].”
Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair
Johnson, D. Y., Ridolfo, A., Mueller, R., Chermack, M., Brockhouse, J., Tadiwala, J., Jain, A., Bertram, K., & Garg, K. (2024) · Advances in Wound Care · doi:10.1089/wound.2024.0077 · Cited by 3
“59,60 Transgenic mice overexpressing folli-statin in skeletal muscle show increased muscle mass. 61 IL-6 62 – 65 It serves as a chemoattractant for myoblasts and myeloid cells, supporting myoblast proliferation.”
Liu, H., Zhang, R., Li, X., Sun, L., Wang, H., Yang, C., Li, L., Wang, J., & Xu, F. (2013) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12104 · Cited by 3
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
Wilton, S. D., & Fletcher, S. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s8762 · Cited by 3
Wilson, E. P., Broadaway, K. A., Parsons, V. A., Vadlamudi, S., Narisu, N., Brotman, S. M., Currin, K. W., Stringham, H. M., Erdos, M. R., Welch, R., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.09.003 · Cited by 4
“62,63 In human adipose tissue, it is downregulated during diet-induced weight loss and correlated with metabolic syndrome risk factors.”
Cadena, S. M., Bogdanovich, S., Khurana, T. S., Pullen, A. E., Pearsall, R. S., Curran, E., Faucette, R., Lane, J., Seehra, J. S., Lachey, J. L., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342666 · Cited by 2
“Members of the transforming growth factor beta (TGF-β ) superfamily, including myostatin (GDF-8) and activin A, are important regulators of skeletal muscle growth [1,2].”
Circulating plasma follistatin follows a 24-hour rhythm in healthy young males
Zilstorff, D. B., Sennels, H. P., Jørgensen, H. L., Albrechtsen, N. J. W., & Richter, M. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag121 · Cited by 1
Пальцын, А. А. (2018) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2018.02.113-121 · Cited by 2
Appendicular lean mass in women with rheumatoid arthritis: Focus on immunological markers
Dobrovolskaya, O. V., Demin, N. V., Feklistov, А. Y., Diatroptov, M. E., Samarkina, E. Y., & Toroptsova, N. V. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-529-534 · Cited by 2
Aged‐Related Fibroblast Activation Protein Expression in Skeletal Muscles Evaluated by PET Imaging
Suh, M., Gil, J., Kang, Y.-K., Choi, H., & Cheon, G. J. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13730 · Cited by 2
Li, X., Wang, J., Liu, H., Wang, H., Sun, L., Yang, C., Li, L., & Zheng, Y. (2014) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2014.07.002 · Cited by 2
“Production and hosting by El leads to prenatal lethality associated with impaired muscle development [9].”
Hosseini, S. R. A., Rad, M. M., & Hejazi, K. (2016) · International Journal of Applied Exercise Physiology · Cited by 4
Rashidlamir, A., Basami, M. R., Hosseini, S. R. A., Hejazi, K., & Anberani, S. M. M. (2016) · Quarterly of Horizon of Medical Sciences · doi:10.18869/acadpub.hms.22.2.111 · Cited by 2
Adult Stem Cells in Hibernation: Future Perspectives of Space Travel
Chen, Y., Aui, S., Lai, Y., & Chang, K. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc19048 · Cited by 2
“myostatin function and promote muscle growth (18).”
Effects of weight loss rate on myostatin and follistatin dynamics in patients with obesity
Kurose, S., Onishi, K., Miyauchi, T., Takahashi, K., & Kimura, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1418177 · Cited by 2
Malek-Zadeh, C. H., Palinkas, M., Watanabe, L. M., Salgado, W., de Vasconcelos, P. B., Regalo, I. H., Siéssere, S., Regalo, S. C. H., & Nonino, C. B. (2024) · Prague Medical Report · doi:10.14712/23362936.2024.30 · Cited by 1
Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors
Goo, Y. T., Grigoriev, V., Korzun, T., Salem, A., Sharma, K. S., Singh, P., Kioussi, C., Taratula, O. R., Marks, D. L., & Taratula, O. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114870 · Cited by 1
Lisco, G., Tullio, A. D., Disoteo, O., Dicorato, P., Tortora, A., Geronimo, V. D., & Triggiani, V. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10033-w · Cited by 1
“Follistatin is a liver-derived endogenous inhibitor that binds myostatin and modulates skeletal muscle growth by antagonizing myostatin activity [36].”
Yamaguchi, Y., Zhu, M., Moaddel, R., Elango, P., Ferrucci, L., & Semba, R. D. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad135 · Cited by 1
Anabolic and anticatabolic agents in kidney disease and kidney failure
Chiang, J. M., & Johansen, K. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00040-9 · Cited by 1
The Effects of Poor Maternal Nutrition on Muscle Development in Lambs
Raja, J. (2013) · OpenCommons - UConn (University of Connecticut) · Cited by 1
Jaffe, I. M. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/thesis-jaffe-ian-2013
“…muscle mass was further enhanced in the complete absence of myostatin through the inhibition of related TGF-β ligands including activin A (Lee et al., 2010), suggesting the participation of additional effectors alongside myostatin in the regulation of mammalian muscle physiology (Lee,…”
InfluentialTaylor, W. A., Evans, N. P., Hertz, C., & Skinner, D. C. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.02.019
Exercise mitigates the effects of hyperhomocysteinemia on adverse skeletal muscle remodeling.
Winchester, L. J. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2224
Colao, A., & Pivonello, C. (2020) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5106-1
From Barbells to Brawns: The Physiology of Resistance Exercise and Skeletal Muscle Growth
Park, J., Mcllvain, V., Rosenberg, J., Donovan, L., Desai, P., & Kim, J. Y. (2022) · The Korean Journal of Sports Medicine · doi:10.5763/kjsm.2022.40.3.151 · Cited by 1
Colao, A. A. L., & Pivonello, C. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5106
RNA-seq analysis of skeletal muscle in motor neurone disease cases and controlsPreprint
Freydenzon, A., Wani, S., Bharti, V., Wallace, L. M., Henders, A. K., McCombe, P., Henderson, R. D., Steyn, F. J., Wray, N. R., Ngo, S. T., et al. (2023) · medRxiv · doi:10.1101/2023.03.13.23287229
“327 FST (follistatin) is a receptor agonist which binds to other transforming growth factor-β 328 ligands, including myostatin and activin-A which would otherwise limit muscle mass without 329 inhibition (44).”
BackgroundCardiokines and cardiac remodeling
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00014-x
Hassan, F., Aftab, S., Rehman, M. S.-U., Arif, S., Safdar, M., Ahmed, S., Ahmad, K., Cerbo, A. D., Azzam, M. M., & Alagawany, M. M. (2025) · Brazilian Journal of Poultry Science · doi:10.1590/1806-9061-2024-2004
Which training model has the best effect on adipo-myokines in men with obesity?Preprint
Razi, O., Hamdi, S., Rahim, H. A., Abednatanzi, H., Najafabadi, M. K., Hejazi, K., Nahand, M. S., Daloii, A. A., Moghadam, A. G., Mollabashi, S. S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6297875/v1
Ramirez-Cisneros, A., de Piñeres, V. G., Tamayo-Torres, C. S., Stefanakis, K., Angelidi, A. M., Fu, L., Anastasiou, G., & Mantzoros, C. S. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70496
The function of Activin receptor type IIB signaling in adult skeletal muscle
Relizani, K. (2014) · theses.fr (ABES) · doi:10.70675/20978d43z02f0z4a1ezb428zf5dab86d9abf
Pagano, A. F. (2016) · theses.fr (ABES) · doi:10.70675/b2e8ea4ez5cd3z43a4zae84z3a8e6d8c661f
“impressionnant d’une masse musculaire quadruplée ! De manière intéressante, cette étude ainsi que la suivante du même groupe (Lee et al., 2010) ont donc montré que la Fstn, malgré l’absence de la Mstn, gardait un impact fonctionnel suggérant ainsi que les mécanismes induisant une prise de masse musculaire par la Fstn…”
BackgroundThe extracellular matrix as a biomaterial to optimize skeletal muscle regeneration
Trignol, A. (2019) · theses.fr (ABES) · doi:10.70675/0610b575z71faz4ea8zb917z1c4ad5f29d23
Oxytocin, as a hormonal treatment for cachexia in preclinical models
Benoni, A. (2022) · theses.fr (ABES) · doi:10.70675/f14dd835z1cb6z471ez8accz6ccfa7f21ff1
Mallard, J. (2022) · theses.fr (ABES) · doi:10.70675/f8b2c96bzc4cdz4249z8e59z5f87c7ca2462
Cerabino, N., Bonfiglio, C., Bonfrate, L., Donvito, R., Pesole, P. L., Stabile, D., Shahini, E., & Giannelli, G. (2026) · Nutrients · doi:10.3390/nu18121873
“However, in the multivariate GEE model, follistatin emerged as a significant predictor of changes in fat mass. Follistatin regulates muscle growth and energy metabolism by inhibiting myostatin and other members of the transforming growth factor-β superfamily [45].”
Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning
Dirakvand, G., Pervin, S., Villa, B., Le, C., Yohanna, K., Grijalva, V. R., Chattopadhyay, A., Sinha, S. K., Reddy, S. T., & Singh, R. (2026) · Cells · doi:10.3390/cells15131205
“Liver, WAT, and heart tissues were harvested for gene and protein expression analyses by Western blotting, immunohistochemistry, and quantitative real-time PCR. Male and female Fst heterozygous ( Fst +/ − ) mice were obtained from Dr. Martin Matzuk (Baylor College of Medicine, Houston, TX, USA) [3].”
Follistatin-Mediated Browning of Adipose Tissue Improves Cardiometabolic Health
Varzideh, F., Gagaring, T., Mone, P., Jankauskas, S. S., Kansakar, U., Pande, S., & Santulli, G. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27910
BindingDB Entry 50046112: Virtual High-Throughput Screening To Identify Novel Activin Antagonists.
BindingDB (2016) · UC San Diego · doi:10.7270/q2rf5wsw
BindingDB (2021) · UC San Diego · doi:10.7270/q2v1287x
Metadata
- Authors
- Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R.
- Affiliations
- Johns Hopkins University (US)
- University of Miami (US)
- Baylor College of Medicine (US)
- Fujita Health University (JP)
- University of Pennsylvania (US)
- ORCID
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-10-01
- Volume
- 24
- Issue
- 10
- Pages
- 1998-2008
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC2954636
- OpenAlex
- W2029816532
- Semantic Scholar
- 50765d8f8086769e58ab3497a6b5260266268e0b
- Cited by
- 273
- References
- 64
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 22 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 22
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (1dp2od004515-01)
- National Institute on Aging (R01AG037193)
- National Cancer Institute (R01CA122596)
- National Institute of General Medical Sciences (R01GM092758)
- National Institute of Neurological Disorders and Stroke (K08NS055879)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR052646, R01AR060636, R01AR059685)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD032067)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- follistatin, myostatin, activin A, TGF-beta superfamily, skeletal muscle mass, muscle fiber type shift, muscle remodeling, tetanic force, muscle atrophy, muscle degeneration, muscle growth
- MeSH terms
- Animals, Humans, Mice, Inbred C57BL, Muscle Contraction, Organ Size, Mice, Knockout, Muscle, Skeletal, Muscle Development, Activins, Follistatin, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.